Adrian Hepner
Found 7 people in Florida, New Jersey, South Carolina and other states
-
+98
-
+97
-
+96
-
-
+94
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sponsored by SpokeoPaid Service
Adrian Hepner, age 40
C*****@aol.com — (970) 270-****
***** Cedar Way, Apt 203, Fruita, CO
View full reportAdrian J Hepner, age 62
A*****@yahoo.com — (919) 720-****
***** Clyden Cv, Raleigh, NC
View full reportAdrian M Hepner, age 39
M*****@yahoo.com — (970) 216-****
***** W Maricopa St, Goodyear, AZ
View full reportSponsored by SpokeoPaid Service
Adrian Hepner
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Adriana Hepner
Lives in Sydney, Australia
Melanoma Medical Oncology Fellow at Melanoma Institute Australia
Bengt Bergstrom MD, Ph.D.
Sci-Engi-Medco Solutions Inc
Education: Lund ...
Reina Benabou, MD, PhD
ReST THERAPEUTICS
Rita Ayala
Parexel
Bridget Martell MA, MD
Two Bear Capital
Education: Yale University School of ...
Oren Cohen
Nestor Molfino, MD, MSc
Amgen
Education: University of Toronto ...
Sophia Randolph MD PhD
ALX Oncology
Education: Harvard University ...
horst schran
Mohamed Eid, MD, MSc, MHA
Chief Medical Officer - Verdiva Bio
Education: University of Minnesota School of Public Health
John May
GenEros BioPharma
Education: Joan & Sanford I. Weill Medical College of Cornell University
Janeen Doyle
Chief Corporate and Business Development Officer
Experience: Janux Therapeutics
Dr Alice Bexon
OncoResponse
Adrian Hepner
Sponsored by PeopleLookerPaid Service
Search for Adrian Hepner's city and state history
Search address history
Newly public biotech co. Coya Therapeutics hires new president, chief medical officer
The Business Journals - Fri, 07 Jul 2023
Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial
Fierce Biotech - Wed, 24 Nov 2021
MDA 2023: COYA 302 therapy slows ALS progression in early trial |...
ALS News Today - Wed, 22 Mar 2023
Coya Therapeutics Secures $10 Million Financing to Advance
GlobeNewswire - Tue, 07 Jun 2022
People
Nature - Fri, 11 Aug 2023
Newly public Coya takes on neurodegenerative disease with Tregs
BioWorld MedTech - Wed, 15 Feb 2023
Lynn Seely brings ex-Myovant colleague to Lyell’s C-suite; Nkarta, Zai Lab name new CFOs
Endpoints News - Fri, 07 Jul 2023
Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 302 development
Mint - Mon, 20 Mar 2023
Adrian Hepner - @adrussia1
0 followers
Adrian Hepner - @adrianhepner
0 followers
Adrian Hepner - Chief Medical Officer @ Coya Therapeutics
www.crunchbase.com
Coya Therapeutics Appoints Dr. Adrian Hepner as Chief Medical ...
Coya Therapeutics Appoints Dr. Adrian Hepner as Chief Medical Officer and Dr. Greg MacMichael as Chief Technical Officer. HOUSTON, Nov. 01, 2021 (GLOBE ...
Adrian Hepner: Positions, Relations and Network - MarketScreener
Adrian Hepner. No open positions remaining. 63 year. 99 connections. Health Technology. Consumer Services. Summary · Experience · Personal Network.
Adrian HEPNER | University of California, Berkeley - ResearchGate
Adrian HEPNER | Cited by 256 | of University of California, Berkeley, Berkeley (UCB) | Read 7 publications | Contact Adrian HEPNER.
Coya Therapeutics Appoints Dr. Adrian Hepner as Chief Medical ...
... Adrian Hepner, M.D., Ph.D. as Chief Medical Officer and Greg MacMichael, Ph.D. as Chief Technical Officer, effective immediately. Dr. Hepner will drive the ...
Adrian Hepner Net Worth (2025) - GuruFocus
The estimated net worth of Adrian Hepner is at least $51,700 dollars as of 2025-04-13. Adrian Hepner is the Chief Medical Officer of Coya Therapeutics Inc ...
News Details - Coya Therapeutics - Investor Relations
Dr. Grossman will succeed Dr. Adrian Hepner in this role, effective July 17 th , 2023, and will leverage his over two decades of clinical development expertise.
Adrian J. Hepner MD, PhD - Executive Bio, Work History, and Contacts
Dr. Hepner has over 30 years of global experience in clinical research and drug development, including the development and implementation of the clinical ...
Adrian Hepner: Profile, Track Record, Trades - Boardroom Alpha
Dr. Adrian Hepner, M.D., Ph.D., President, Chief Medical Officer Dr. Hepner has been our Chief Medical Officer since November 2021. Dr. Hepner has over 30 ...
Adrian Hepner | Eagle Pharmaceuticals | United States of America
Adrian Hepner. Executive Vice President Pharmaceuticals Eagle Pharmaceuticals United States of America. Biography. Dr. Hepner has over 25 years of experience ...
Adrian Hepner - Eagle Pharmaceuticals Insider Transactions ...
Adrian Hepner, EVP and Chief Medical Officer at Eagle Pharmaceuticals, holds 10.00K shares in Coya Therapeutics, Inc. (Ticker: COYA), holds 48.78K shares in ...
Adrian HEPNER Inventions, Patents and Patent Applications - Justia ...
Adrian HEPNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that ...
Former President, Chief Medical Officer Adrian Hepner salary at ...
As Former President, Chief Medical Officer at COYA THERAPEUTICS INC, Adrian Hepner made $622,158 in total compensation. Of this total $285,208 was received ...
BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. ...
(Nasdaq: BDSI) announced that Adrian Hepner, M.D., Ph.D., has joined the company as Vice President of Clinical Research and Regulatory Affairs. Dr. Hepner ...
Adrian Hepner Salary Infomation 2019
Adrian Hepner made $2,680,225 in total compensation as Executive Vice President and Chief Medical Officer at Eagle Pharmaceuticals Inc in 2019. $933,560 was ...
Adrian Hepner Family History Records - Ancestry® - Ancestry.com
Results for "Adrian Hepner". 1 - 2 of 2 Records. Adrian Hepner. Birth: 3 Sep 1914 Illinois. Death: 9 Jun 1982 Marseilles, La Salle, Illinois, United States of ...
Adrian Hepner's Insider Trades & SAST Disclosures - Trendlyne.com
Adrian Hepner's most recent trade in Coya Therapeutics Inc was a trade of 115,000 Stock Option (right to buy) done . Disclosure was reported to the exchange ...
News Details - Eagle Pharmaceuticals, Inc.
“A substantial number of women with advanced HR-positive breast cancer receiving standard treatment experience early disease progression,” said Adrian Hepner, ...
Examining Charcot-Marie-Tooth with Florian Thomas, MD ... - HCPLive
Examining Charcot-Marie-Tooth with Florian Thomas, MD, and Adrian Hepner, MD ... Adrian Hepner, MD, Chief Medical Officer of Pharnext ...
coya-ex106_152.htm - SEC.gov
(the “Company”) and Adrian Hepner (“Executive”). 1.Position ... Adrian Hepner. Dated: 8/15/2022. Dated: 8/12/2022. -7-. EXHIBIT A. PROPRIETARY ...